SAMHSA is announcing the availability of up to $4.7 million for Improving Access to Overdose Treatment grants

Monday, April 9, 2018

The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting applications for Improving Access to Overdose Treatment (Short Title: OD Treatment Access) grants totaling up to $4.7 million over the next five years.

SAMHSA will award OD Treatment Access funds to Federally Qualified Health Centers (FQHC), Opioid Treatment Programs, or practitioners who have a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose. The recipients will partner with other prescribers at the community level to develop best practices for prescribing and co-prescribing FDA-approved overdose reversal drugs. After developing best practices, the recipient will train other prescribers in key community sectors as well as individuals who support persons at high risk for overdose.

SAMHSA expects to fund up to 5 grantees with up to $200,000 per year for up to five years.  The actual award amount may vary, depending on the availability of funds. The funding opportunity announcement for this grant is available at: https://www.samhsa.gov/grants/grant-announcements/sp-18-006.

WHO CAN APPLY: SAMHSA is limiting eligibility to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs as defined under part 8 of title 42, Code of Federal Regulations, and practitioners dispensing narcotic drugs pursuant to section 303(g) of the Controlled Substances Act. See Section III-1 of the Funding Opportunity Announcement (FOA) for complete eligibility information in accordance with Section 544 of the Public Health Service Act.

HOW TO APPLY: All applicants must register with the National Institutes of Health’s electronic Research Administration (eRA) Commons in order to submit an application.  This process takes up to six weeks.  If you believe you are interested in applying for this opportunity, you MUST start the registration process immediately.  Do not wait to start this process.  If your organization is not registered and you do not have an active eRA Commons PI account by the deadline, the application will not be accepted. Applicants also must register with the System for Award Management at SAM.gov and Grants.gov/.

APPLICATION DUE DATE:  June 4, 2018 by 11:59 pm (Eastern Time).  Applications must be received by the due date and time to be considered for review. 

ADDITIONAL INFORMATION:  Applicants with questions about program issues should contact Tonia F. Gray at (240) 276-2492 or Tonia.Gray@samhsa.hhs.gov. In addition, you may also contact Kim Nesbitt at (240) 276-1742 or Kim.Nesbitt@samhsa.hhs.gov

For questions on grants management issues contact Eileen Bermudez at (240) 276-1412 or FOACSAP@samhsa.hhs.gov.  

For more information, contact the SAMHSA Press Office at 240-276-2130.


The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services (DHHS) that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.

Last Updated: 04/09/2018